Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
  1. 4 Shares withheld for taxes EVP & General Counsel gave up 517 shares (to pay taxes)
  2. 4 Open-market sale EVP & General Manager US sold 43,993 shares at an average $83.49 ($3,672,887)
  3. 4 Grant or award Director acquired 880 shares (grant or award)
  4. 4 Grant or award Director acquired 280 shares (grant or award)
  5. 4 Grant or award Director acquired 240 shares (grant or award)
  6. 4 Grant or award Director acquired 249 shares (grant or award)
  7. 4 Grant or award Director acquired 326 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy Director bought 389,080 shares at an average $72.24 ($28,107,770)
  10. 4 Open-market buy Director bought 525,804 shares at an average $67.96 ($35,734,890)
  11. 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 1,177 shares (to pay taxes)
  12. 4 Open-market buy Director bought 1,598,374 shares at an average $66.91 ($106,952,404)
  13. 4 Open-market sale EVP, General Manager, Europe sold 7,375 shares at $74.19 ($547,151)
  14. 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 78 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP, General Manager, Europe gave up 78 shares (to pay taxes)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 20 of 82 · 1,628 filings